Synthesis and biological evaluation of novel substituted 1,3,4-thiadiazole and 2,6-di aryl substituted imidazo [2,1-b] [1,3,4] thiadiazole derivatives

dc.contributor.authorChandrakantha, B.
dc.contributor.authorIsloor, A.M.
dc.contributor.authorShetty, P.
dc.contributor.authorFun, H.-K.
dc.contributor.authorHegde, G.
dc.date.accessioned2026-02-05T09:34:18Z
dc.date.issued2014
dc.description.abstractA new series of N-[5-(4-(alkyl/aryl)-3-nitro-phenyl)-[1,3,4-thiadiazol-2- yl]-2,2-dimethyl-propionamide 4 (a-l) and 6-(4-Methoxy-phenyl)-2-(4-alkyl/aryl)- 3-nitro-phenyl)-Imidazo [2,1-b] [1,3,4] thiadiazole 6 (a-l) were synthesized starting from 5-(4-Fluoro-3-nitro-phenyl)-[1,3,4] thiadiazole-2-ylamine. The synthesized compounds were characterized by IR, NMR, mass spectral and elemental analysis. All the compounds were tested for antibacterial and antifungal activities. The antimicrobial activities of the compounds were assessed by well plate method (zone of inhibition). Compounds 4a, 4c and 6e, 6g displayed appreciable activity at the concentration 0.5-1.0 mg/mL.© 2013 Elsevier Masson SAS. All rights reserved.
dc.identifier.citationEuropean Journal of Medicinal Chemistry, 2014, 71, , pp. 316-323
dc.identifier.issn2235234
dc.identifier.urihttps://doi.org/10.1016/j.ejmech.2013.10.056
dc.identifier.urihttps://idr.nitk.ac.in/handle/123456789/26539
dc.publisherElsevier Masson s.r.l.
dc.subject(2,4 difluoro benzyl) [4 [6 (4 methoxy phenyl) imidazo [2,1 b] [1,3,4] thiadiazol 2 yl) 2 nitro phenyl) aminei
dc.subject(4 fluoro phenyl) [4 [6(4 methoxy phenyl) imidazo [2,1 b] [1,3,4] thiadiazol 2 yl] 2 nitro phenyl] amine
dc.subject2,2 dimethyl n (5 [3 nitro 4 [4 (4 trifluoromethyl phenyl) piperdin 1 yl] phenyl) [1,3,4] thiadiazol 2 yl) propionamide
dc.subject2,2 dimethyl n (5 [3 nitro 4 [tetrahydro furan 2 ylmethyl) amino] phenyl] [1,3,4] thiadiazol 2 yl) propionamide
dc.subject2,2 dimethyl n [5 (4 morpholin 4 yl 3 nitro phenyl) [1,3,4] thiadiazo 2 yl] propionamide
dc.subject2,2 dimethyl n [5 [4 (4 methyl piperazin 1 yl) 3 nitro phenyl] [1,3,4]thiadiazol 2 yl) propionamide
dc.subject6 (4 methoxy phenyl) 2 (3 nitro 4 pyrrolidin 1 yl phenyl) imidazo [2,1 b] [1,3,4] thiadiazol
dc.subject6 (4 methoxy phenyl) 2 [3 nitro 4 [4 (4 trifluoromethyl phenyl) piperidine 1 yl] phenyl imidazo
dc.subject6 (4 methoxy phenyl) 2 [4 (4 methyl piperazin 1 yl) 3 nitro phenyl] imidazo [2,1 b] [1,3,4] thiadiazole
dc.subject6 (4 methoxy phenyl) 2 [4 morpholin 4 1 yl) 3 nitro phenyl] imidazo [2,1 b] [1,3,4 thiadiazole
dc.subjectantifungal agent
dc.subjectantiinfective agent
dc.subjectbutyl [4 [6 (4 methoxy phenyl) imidazo [2,1 b] [1,3,4] thiadiazol 2 yl] 2 nitro phenyl) amine
dc.subjectcyclohexyl [4 [6 (4 methoxy phenyl) imidazo [2,1 b] [1,3,4] thiadiazol 2 yl] 2 nitro phenyl) amine
dc.subjectcyclopentyl [4 [6 (4 methoxy phenyl) imidazo [2,1 b] [1,3,4] thiadiazol 2 yl] 2 nitro phenyl) amine
dc.subjectdiethyl [4 [6 (4 methoxy phenyl) imidazo [2,1 b] [1,3,4] thiadiazol 2 yl] 2 nitro phenyl) amine
dc.subjectn [5 (3 nitro 4 pyrrolidin 1 yl phenyl) [1,3,4] thiadiazol 2 yl] 2,2 dimethyl propionamide
dc.subjectn [5 (4 butylamino 3 nitro phenyl) [1,3,4] thiadiazol 2 yl] 2,2 dimethyl propionamide
dc.subjectn [5 (4 cyclohexylamino 3 nitro phenyl) [1,3,4] thiadiazol 2 yl] 2,2 dimethyl propionamide
dc.subjectn [5 (4 cyclopentylamino 3 nitro phenyl) [1,3,4] thiadiazol 2 yl] 2,2 dimethyl propionamide
dc.subjectn [5 (4 diethylamino 3 nitro phenyl) [1,3,4] thiadiazol 2 yl] 2,2 dimethyl propionamide
dc.subjectn [5 (4 dimethylamino 3 nitro phenyl) [1,3,4] thiadiazol 2 yl] 2,2 dimethyl propionamide
dc.subjectn [5 [4 (2,4 di fluoro benzylamino) 3 nitro phenyl) [1,3,4] thiadiazol 2 yl] 2,2 dimethyl propionamide
dc.subjectthiadiazole derivative
dc.subjectunclassified drug
dc.subject[4 [6 (4 methoxy phenyl) imidazo [2,1 b] [1,3,4] thiadiazol 2 yl] 2 nitro phenyl) dimethyl amine
dc.subject[4 [6 (4 methoxy phenyl)imidazo [2,1 b] [1,3,4] thiadiazol 2 yl] 2 nitro phenyl) (tetrahydro furan 2 ylmethyl) amine
dc.subjectantibacterial activity
dc.subjectantifungal activity
dc.subjectantimicrobial activity
dc.subjectarticle
dc.subjectAspergillus flavus
dc.subjectBacillus subtilis
dc.subjectCandida albicans
dc.subjectcarbon nuclear magnetic resonance
dc.subjectChrysosporium
dc.subjectdrug synthesis
dc.subjectEscherichia coli
dc.subjectfungal strain
dc.subjectproton nuclear magnetic resonance
dc.subjectPseudomonas aeruginosa
dc.subject1,3,4-Thiadiazole
dc.subject2,6-Diaryl imidazo [2,1-b] [1,3,4] thiadiazole
dc.subjectAntibacterial
dc.subjectAntifungal activity
dc.subjectAnti-Bacterial Agents
dc.subjectAntifungal Agents
dc.subjectBacteria
dc.subjectBacterial Infections
dc.subjectFungi
dc.subjectHumans
dc.subjectMicrobial Sensitivity Tests
dc.subjectMycoses
dc.subjectThiadiazoles
dc.titleSynthesis and biological evaluation of novel substituted 1,3,4-thiadiazole and 2,6-di aryl substituted imidazo [2,1-b] [1,3,4] thiadiazole derivatives

Files

Collections